Showing results (101-110 of 215) with videos related to

Sort By:
Pageof 22
AIDS (London, England)|December 2, 2024
Psychosocial factors account for a proportion of the difference in cognitive performance between persons with and without HIVAnna Jane Dreyer, Celine Le Roux, Kevin G F Thomas, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 10, 2021
Safety of Tenofovir Alafenamide in People With HIV Who Experienced Proximal Renal Tubulopathy on Tenofovir Disoproxil FumarateLucy Campbell, Birgit Barbini, Keith Burling, et al.
AIDS (London, England)|December 3, 2019
Defining cerebrospinal fluid HIV RNA escape: editorial review AIDSAlan Winston, Andrea Antinori, Paola Cinque, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 2, 2016
Cognitive Function in Young Persons With and Without Perinatal HIV in the AALPHI Cohort in England: Role of Non-HIV-Related FactorsAli Judd, Marthe Le Prevost, Diane Melvin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 3, 2020
Increased Body Mass Index and Type 2 Diabetes Are the Main Predictors of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Liver Biopsies of Patients With Human Immunodeficiency Virus MonoinfectionJames B Maurice, Robert Goldin, Andrew Hall, et al.
Sexually Transmitted Infections|February 23, 2013
Effect of time since exposure to Chlamydia trachomatis on chlamydia antibody detection in women: a cross-sectional studyPatrick J Horner, Gillian S Wills, Rosy Reynolds, et al.
Plos One|September 15, 2022
Learning and memory function in young people with and without perinatal HIV in EnglandAlejandro Arenas-Pinto, Ali Judd, Diane Melvin, et al.
AIDS (London, England)|June 10, 2020
First-line HIV treatment outcomes following the introduction of integrase inhibitors in UK guidelinesKate El Bouzidi, Sophie Jose, Andrew N Phillips, et al.
The Journal of Antimicrobial Chemotherapy|February 14, 2014
Rilpivirine exposure in plasma and sanctuary site compartments after switching from nevirapine-containing combined antiretroviral therapyBorja Mora-Peris, Victoria Watson, Jaime H Vera, et al.
Pageof 22